Monte, F.B.d.M.; Montagnoli, T.L.; Dematté, B.E.; Gubert, F.; Ventura, V.S.; da Silva, J.S.; Trachez, M.M.; Mendez-Otero, R.; Zapata-Sudo, G.
Antinociceptive Effect of the Combination of a Novel α4β2* Agonist with Donepezil in a Chronic Pain Model. Biomedicines 2023, 11, 3249.
https://doi.org/10.3390/biomedicines11123249
AMA Style
Monte FBdM, Montagnoli TL, Dematté BE, Gubert F, Ventura VS, da Silva JS, Trachez MM, Mendez-Otero R, Zapata-Sudo G.
Antinociceptive Effect of the Combination of a Novel α4β2* Agonist with Donepezil in a Chronic Pain Model. Biomedicines. 2023; 11(12):3249.
https://doi.org/10.3390/biomedicines11123249
Chicago/Turabian Style
Monte, Fernanda B. de M., Tadeu L. Montagnoli, Bruno E. Dematté, Fernanda Gubert, Vitória S. Ventura, Jaqueline S. da Silva, Margarete M. Trachez, Rosalia Mendez-Otero, and Gisele Zapata-Sudo.
2023. "Antinociceptive Effect of the Combination of a Novel α4β2* Agonist with Donepezil in a Chronic Pain Model" Biomedicines 11, no. 12: 3249.
https://doi.org/10.3390/biomedicines11123249
APA Style
Monte, F. B. d. M., Montagnoli, T. L., Dematté, B. E., Gubert, F., Ventura, V. S., da Silva, J. S., Trachez, M. M., Mendez-Otero, R., & Zapata-Sudo, G.
(2023). Antinociceptive Effect of the Combination of a Novel α4β2* Agonist with Donepezil in a Chronic Pain Model. Biomedicines, 11(12), 3249.
https://doi.org/10.3390/biomedicines11123249